Page 5 - Everett Cunningham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EXAS earnings call for the period ending September 30, 2023.

Banque Pictet & Cie SA grew its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 0.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 295,013 shares of the medical research company’s stock after purchasing an additional 2,287 shares during the […]

Exact Sciences (NASDAQ:EXAS – Free Report) had its target price decreased by Piper Sandler from $90.00 to $80.00 in a research note issued to investors on Monday, Benzinga reports. Piper Sandler currently has an overweight rating on the medical research company’s stock. A number of other research firms have also weighed in on EXAS. The […]

Private Trust Co. NA acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 480 shares of the medical research company’s stock, valued at approximately $45,000. A number of other institutional investors and […]

EFG Asset Management North America Corp. lowered its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,089 shares of the medical research company’s stock after selling […]